ATP-Binding Pocket-Targeted Suppression of Src and Syk by Luteolin Contributes to Its Anti-Inflammatory Action

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Lee, Jeong Oog ^a   Jeong, Deok ^b   Kim, Mi Yeon ^c   Cho, Jae Youl ^b  

^a Konkuk University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Soongsil University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LUTEOLIN; MESSENGER RNA; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN KINASE SYK; PROTEIN P50; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; SYK PROTEIN, HUMAN; SYK PROTEIN, MOUSE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTEMISIA; ARTEMISIA ASIATICA; ARTICLE; CELL VIABILITY; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUCIFERASE ASSAY; MACROPHAGE; MOUSE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; METABOLISM;

ARTEMISIA ASIATICA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE 2; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUTEOLIN; MICE; NITRIC OXIDE; PROTEIN-TYROSINE KINASES; SRC-FAMILY KINASES; SYK KINASE;

EID: 84937776460     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/967053     Document Type: Article

References (40)

1. H. J. Song, C. Y. Shin, T. Y. Oh, and U. D. Sohn, "The protective effect of eupatilin on indomethacin-induced cell damage in cultured feline ileal smooth muscle cells: involvement of HO- 1 and ERK," Journal of Ethnopharmacology, vol. 118, no. 1, pp. 94-101, 2008.
2. K. Huh, T. H. Kwon, U. S. Shin et al., "Inhibitory effects of DA- 9601 on ethanol-induced gastrohemorrhagic lesions and gastric xanthine oxidase activity in rats," Journal of Ethnopharmacology, vol. 88, no. 2-3, pp. 269-273, 2003.
3. D. Jeong, Y.-S. Yi, G.-H. Sung et al., "Anti-inflammatory activities andmechanisms ofArtemisia asiatica ethanol extract," Journal of Ethnopharmacology, vol. 152, no. 3, pp. 487-496, 2014.
4. M. R. Alavala, J. Y. Lee, H. S. Jee et al., "Artemisolide from Artemisia asiatica: nuclear factor-kappaB (NF-kappaB) inhibitor suppressing prostaglandin E2 and nitric oxide production in macrophages," Archives of Pharmacal Research, vol. 29, no. 7, pp. 591-597, 2006.
5. D.-H. Kim, H.-K. Na, T. Y. Oh, W.-B. Kim, and Y.-J. Surh, "Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces cell cycle arrest in ras-transformed human mammary epithelial cells," Biochemical Pharmacology, vol. 68, no. 6, pp. 1081-1087, 2004.
6. D. Kalemba, D. Kusewicz, and K. ͆wiąder, "Antimicrobial properties of the essential oil of Artemisia asiatica Nakai," Phytotherapy Research, vol. 16, no. 3, pp. 288-291, 2002.
7. J. E. Son, E. Lee, S. G. Seo et al., "Eupatilin, a major flavonoid of artemisia, attenuates aortic smooth muscle cell proliferation and migration by inhibiting PI3K, MKK3/6, and MKK4 activities," Planta Medica, vol. 79, no. 12, pp. 1009-1016, 2013.
8. M. Cai, P.-T. T. Phan, J. G. Hong et al., "The neuroprotective effect of eupatilin against ischemia/reperfusion-induced delayed neuronal damage in mice," European Journal of Pharmacology, vol. 689, no. 1-3, pp. 104-110, 2012.
9. L. Zhu, W. Bi, D. Lu, C. Zhang, and X. Shu, "Luteolin inhibits SH-SY5Y cell apoptosis through suppression of the nuclear transcription factor-κB, mitogen-activated protein kinase and protein kinase B pathways in lipopolysaccharide-stimulated cocultured BV2 cells," Experimental and Therapeutic Medicine, vol. 7, no. 5, pp. 1065-1070, 2014.
10. C. M. Park and Y. S. Song, "Luteolin and luteolin-7-O-glucoside inhibit lipopolysaccharide-induced inflammatory responses through modulation of NF-kappaB/Ap-1/PI3K-AKT signaling cascades in RAW 264.7 cells," Nutrition Research and Practice, vol. 7, no. 6, pp. 423-429, 2013.
11. Y. Nishitani, K. Yamamoto, M. Yoshida et al., "Intestinal antiinflammatory activity of luteolin: role of the aglycone in NF- κB inactivation in macrophages co-cultured with intestinal epithelial cells," BioFactors, vol. 39, no. 5, pp. 522-533, 2013.
12. K.-C. Chen, C.-Y. Chen, C.-R. Lin et al., "Luteolin attenuates TGF-β1-induced epithelial-mesenchymal transition of lung cancer cells by interfering in the PI3K/Akt-NF-κB-Snail pathway," Life Sciences, vol. 93, no. 24, pp. 924-933, 2013.
13. S.-H. Park, J.-H. Kim, D.-H. Lee et al., "Luteolin 8-C-β- fucopyranoside inhibits invasion and suppresses TPA-induced MMP-9 and IL-8 via ERK/AP-1 and ERK/NF-κB signaling in MCF-7 breast cancer cells," Biochimie, vol. 95, no. 11, pp. 2082-2090, 2013.
14. C. Xie, J. Kang, Z. Li et al., "The açaí flavonoid velutin is a potent anti-inflammatory agent: blockade of LPS-mediated TNF-α and IL-6 production through inhibiting NF-κB activation and MAPKpathway," Journal ofNutritional Biochemistry, vol. 23, no. 9, pp. 1184-1191, 2012.
15. K.-J. Yang, S. Shin, L. Piao et al., "Regulation of 3- phosphoinositide-dependent protein kinase-1 (PDK1) by Src involves tyrosine phosphorylation of PDK1 and Src homology 2 domain binding," The Journal of Biological Chemistry, vol. 283, no. 3, pp. 1480-1491, 2008.
16. S. E. Byeon, T. Yu, Y. Yang et al., "Hydroquinone regulates hemeoxygenase-1 expression via modulation of Src kinase activity through thiolation of cysteine residues," Free Radical Biology and Medicine, vol. 57, pp. 105-118, 2013.
17. T. Shen, W. S. Yang, Y.-S. Yi et al., "AP-1/IRF-3 targeted anti-inflammatory activity of andrographolide isolated from Andrographis paniculata," Evidence-Based Complementary and AlternativeMedicine, vol. 2013, Article ID210736, 16pages, 2013.
18. C. K. Youn, S. J. Park, M. Y. Lee et al., "Silibinin inhibits LPSinducedmacrophage activation by blocking p38MAPKinRAW 264.7 cells," Biomolecules and Therapeutics, vol. 21, no. 4, pp. 258-263, 2013.
19. R. Pauwels, J. Balzarini, M. Baba et al., "Rapid and automated tetrazolium-based colorimetric assay for the detection of anti- HIV compounds," Journal of Virological Methods, vol. 20, no. 4, pp. 309-321, 1988.
20. T. Yayeh, K.-H. Jung, H. Y. Jeong et al., "Korean red ginseng saponin fraction downregulates proinfl ammatory mediators in LPS stimulated RAW264.7 cells and protects mice against endotoxic shock," Journal of Ginseng Research, vol. 36, no. 3, pp. 263-269, 2012.
21. Y. G. Lee, B. M. Chain, and J. Y. Cho, "Distinct role of spleen tyrosine kinase in the early phosphorylation of inhibitor of kappaB alpha via activation of the phosphoinositide-3-kinase and Akt pathways," International Journal of Biochemistry and Cell Biology, vol. 41, no. 4, pp. 811-821, 2009.
22. G.-J. Kang, S.-C. Han, J.-W. Ock, H.-K. Kang, and E.-S. Yoo, "Anti-inflammatory effect of quercetagetin, an active component of immature Citrus unshiu, in HaCaT human keratinocytes," Biomolecules and Therapeutics, vol. 21, no. 2, pp. 138-145, 2013.
23. S. H. Sohn, S. K. Kim, Y. O. Kim et al., "A comparison of antioxidant activity of Korean White and Red Ginsengs on H2O2-induced oxidative stress in HepG2 hepatoma cells," Journal of Ginseng Research, vol. 37, no. 4, pp. 442-450, 2013.
24. S. E. Byeon, Y. G. Lee, B. H. Kim et al., "Surfactin blocks NO production in lipopolysaccharide-activated macrophages by inhibiting NF-κB activation," Journal of Microbiology and Biotechnology, vol. 18, no. 12, pp. 1984-1989, 2008.
25. J.-A. Lee, M.-Y. Lee, I.-S. Shin, C.-S. Seo, H. Ha, and H. K. Shin, "Anti-inflammatory effects of Amomum compactum on RAW 264.7 cells via induction of heme oxygenase-1," Archives of Pharmacal Research, vol. 35, no. 4, pp. 739-746, 2012.
26. T. Shen, J. Lee, M.H. Park et al., "GinsenosideRp1, a ginsenoside derivative, blocks promoter activation of iNOS and Cox-2 genes by suppression of an IKKβ-mediated NF-κB pathway in HEK293 cells," Journal of Ginseng Research, vol. 35, no. 2, pp. 200-208, 2011.
27. S. B. Song, N. H. Tung, T. H. Quang, N. T. T. Ngan, K. E. Kim, and Y. H. Kim, "Inhibition of TNF-α-mediated NF- κB transcriptional activity in HepG2 cells by dammaranetype saponins from Panax ginseng leaves," Journal of Ginseng Research, vol. 36, no. 2, pp. 146-152, 2012.
28. K. K. Jung, H. S. Lee, J. Y. Cho et al., "Inhibitory effect of curcumin on nitric oxide production from lipopolysaccharideactivated primary microglia," Life Sciences, vol. 79, no. 21, pp. 2022-2031, 2006.
29. T. Yu, J. Shim, Y. Yang et al., "3-(4-(tert-Octyl)phenoxy)propane- 1, 2-diol suppresses inflammatory responses via inhibition of multiple kinases," Biochemical Pharmacology, vol. 83, no. 11, pp. 1540-1551, 2012.
30. J. Y. Lee, Y. G. Lee, K.-J. Yang et al., "Akt Cys-310-targeted inhibition by hydroxylated benzene derivatives is tightly linked to their immunosuppressive effects," The Journal of Biological Chemistry, vol. 285, no. 13, pp. 9932-9948, 2010.
31. H.-J. Seo and Y.-J. Surh, "Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces apoptosis in human promyelocytic leukemia cells," Mutation Research: Genetic Toxicology and EnvironmentalMutagenesis, vol. 496, no. 1-2, pp. 191-198, 2001.
32. Z. Hajdú, J. Hohmann, P. Forgo, I. Máthé, J. Molnár, and I. Zupkó, "Antiproliferative activity of Artemisia asiatica extract and its constituents on human tumor cell lines," Planta Medica, vol. 80, no. 18, pp. 1692-1697, 2014.
33. M. J. Hossen, K. S. Baek, E. Kim et al., "In vivo and in vitro anti-inflammatory activities of Persicaria chinensis methanolic extract targeting Src/Syk/NF-kappaB," Journal of Ethnopharmacology, vol. 159, pp. 9-16, 2015.
34. G. Lolli, G. Cozza, M. Mazzorana et al., "Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight," Biochemistry, vol. 51, no. 31, pp. 6097-6107, 2012.
35. R. Cao, N. Mi, and H. Zhang, "3D-QSAR study of c-Src kinase inhibitors based on docking," Journal of Molecular Modeling, vol. 16, no. 2, pp. 361-375, 2010.
36. C.-Y. Chen, W.-H. Peng, K.-D. Tsai, and S.-L. Hsu, "Luteolin suppresses inflammation-associated gene expression by blocking NF-κB and AP-1 activation pathway in mouse alveolar macrophages," Life Sciences, vol. 81, no. 23-24, pp. 1602-1614, 2007.
37. M. J. Smolinska, N. J. Horwood, T. H. Page, T. Smallie, and B. M. J. Foxwell, "Chemical inhibition of Src family kinases affectsmajorLPS-activatedpathways inprimaryhuman macrophages," Molecular Immunology, vol. 45, no. 4, pp. 990-1000, 2008.
38. Y. Yi, Y. Son, C. Ryou, G. Sung, J. Kim, and J. Y. Cho, "Functional roles of Syk in macrophage-mediated inflammatory responses," Mediators of Inflammation, vol. 2014, Article ID 270302, 12 pages, 2014.
39. T. T. M. Dung, S. C. Kim, B. C. Yoo et al., "(5-Hydroxy-4-oxo- 4H-pyran-2-yl)methyl 6-hydroxynaphthalene-2-carboxylate, a kojic acid derivative, inhibits inflammatory mediator production via the suppression of Syk/Src and NF-kappaB activation," International Immunopharmacology, vol. 20, no. 1, pp. 37-45, 2014.
40. M. Endale, S.-C. Park, S. Kim et al., "Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW264.7 cells," Immunobiology, vol. 218, no. 12, pp. 1452-1467, 2013.